Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

June 18, 2025

Study Completion Date

March 26, 2028

Conditions
Multiple MyelomaRelapseRefractoryAgingCo-morbidity
Interventions
DRUG

Isatuximab

Pharmaceutical form: Solution for infusion. Route of administration: Intravenous 10 mg/kg will be administered intravenously once weekly during cycle 1 and every other week during each subsequent cycle.

DRUG

Pomalidomide

Pharmaceutical form: Pill for oral use. Route of administration: 3 mg Pomalidomide 3 mg pill will be taken by mouth once daily on days 1-21 of each 28-day cycle.

DRUG

Dexamethasone

Pharmaceutical form: Tablet for oral use Route of administration: Pill for oral use. Dexamethasone 20 mg tablet will be taken by mouth once per week.

Trial Locations (2)

27157

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem

27514

Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

UNC Lineberger Comprehensive Cancer Center

OTHER